Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs.
Mibefradil was withdrawn from the market in 1998 because of potentially harmful interactions with other drugs.
For the treatment of angina and high blood pressure.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.